Inhibition potentiates immunogenicity in Merkel cell carcinoma: a promising approach to overcome resistance to anti-PD-1 immunotherapy

被引：0

作者：

Chen, Wenwen ^{[1
]}

Bhatia, Shailender ^{[1
]}

Brohl, Andrew S. ^{[2
]}

Chandra, Sunandana ^{[3
]}

Dakhil, Sumia ^{[1
]}

Fecher, Leslie A. ^{[4
]}

Gao, Ling ^{[5
]}

Gooley, Ted A. ^{[6
]}

Hanna, Glenn J. ^{[7
]}

Hibbert, Reina

Kelly, Ciara M. ^{[8
]}

Kiriluk, Samantha M.

Lewis, Karl ^{[9
]}

Moschos, Stergios ^{[10
]}

Nghiem, Paul ^{[11
]}

Thompson, John A. ^{[1
]}

Tykodi, Scott S. ^{[1
]}

机构：

[1] Univ Washington, Seattle, WA USA

[2] Moffit Canc Ctr, Tampa, FL USA

[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA

[4] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA

[5] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA

[6] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA USA

[7] Dana Farber Canc Inst, Boston, MA USA

[8] Mem Sloan Kettering Canc Ctr, New York, NY USA

[9] Univ Colorado Canc Ctr, Anschutz Med Campus, Aurora, CO USA

[10] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[11] Univ Washington, Div Dermatol, Seattle, WA USA

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2022年 / 142卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：2837 / 2837

页数：1

共 50 条

[31] Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours
Melero, Ignacio
de Miguel Luken, Maria
de Velasco, Guillermo
Garralda, Elena
Martin-Liberal, Juan
Joerger, Markus
Alonso, Guzman
Goebeler, Maria-Elisabeth
Schuler, Martin
Koenig, David
Dummer, Reinhard
Reig, Maria
Rodriguez Ruiz, Maria-Esperanza
Calvo, Emiliano
Esteban-Villarrubia, Jorge
Oberoi, Arjun
Sabat, Paula
Soto-Castillo, Juan Jose
Koster, Kira-Lee
Saavedra, Omar
Sayehli, Cyrus
Gromke, Tanja
Laeubli, Heinz
Ramelyte, Egle
Fortuny, Marta
Landa-Magdalena, Ana
Moreno, Irene
Torres-Jimenez, Javier
Hernando-Calvo, Alberto
Hess, Dagmar
Racca, Fabricio
Richly, Heike
Schmitt, Andreas M.
Eggenschwiler, Corinne
Sanduzzi-Zamparelli, Marco
Vilalta-Lacarra, Anna
Trojan, Joerg
Koch, Christine
Galle, Peter R.
Foerster, Friedrich
Trajanoski, Zlatko
Hackl, Hubert
Gogolla, Falk
Koll, Florestan J.
Wild, Peter
Chun, Felix Kyoung Hwan
Reis, Henning
Lloyd, Peter
Machacek, Matthias
Gajewski, Thomas F.
NATURE, 2025, 637 (8048) : 1218 - 1227
[32] PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti-PD-1 Immunotherapy
Zheng, Yimin
Wang, Yining
Lu, Zhou
Wan, Jinkai
Jiang, Lulu
Song, Danjun
Wei, Chuanyuan
Gao, Chao
Shi, Guoming
Zhou, Jian
Fan, Jia
Ke, Aiwu
Zhou, Lu
Cai, Jiabin
ADVANCED SCIENCE, 2023, 10 (29)
[33] Anti-PD-1/PD-L1 immunotherapy in conversion treatment of locally advanced hepatocellular carcinoma
Chen, Jiaqi
Zhang, Ding
Yuan, Ying
CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (03) : 579 - 590
[34] IFNa Potentiates Anti-PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment
Hu, Bo
Yu, Mincheng
Ma, Xiaolu
Sun, Jialei
Liu, Chenglong
Wang, Chunyan
Wu, Suiyi
Fu, Peiyao
Yang, Zhen
He, Yungang
Zhu, Yuanyuan
Huang, Cheng
Yang, Xinrong
Shi, Yinghong
Qiu, Shuangjian
Sun, Huichuan
Zhu, Andrew X.
Zhou, Jian
Xu, Yang
Zhu, Di
Fan, Jia
CANCER DISCOVERY, 2022, 12 (07) : 1718 - 1741
[35] Anti-PD-1/PD-L1 immunotherapy in conversion treatment of locally advanced hepatocellular carcinoma
Jiaqi Chen
Ding Zhang
Ying Yuan
Clinical and Experimental Medicine, 2023, 23 : 579 - 590
[36] Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy
DeVito, Nicholas C.
Sturdivant, Michael
Thievanthiran, Balamayooran
Xiao, Christine
Plebanek, Michael P.
Salama, April K. S.
Beasley, Georgia M.
Holtzhausen, Alisha
Novotny-Diermayr, Veronica
Strickler, John H.
Hanks, Brent A.
CELL REPORTS, 2021, 35 (05):
[37] Early effector T-cell densities predict response in patients with advanced Merkel cell carcinoma treated with anti-PD-1
Lu, S.
Succaria, F.
Green, B.
Giraldo-Castillo, N.
Taube, J.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S119 - S119
[38] Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma
Yinli Yang
Cong Wang
Haiyan Sun
Zhansheng Jiang
Yu Zhang
Zhanyu Pan
Cancer Gene Therapy, 2021, 28 : 89 - 97
[39] Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma
Yang, Yinli
Wang, Cong
Sun, Haiyan
Jiang, Zhansheng
Zhang, Yu
Pan, Zhanyu
CANCER GENE THERAPY, 2021, 28 (1-2) : 89 - 97
[40] Midazolam exhibits antitumour and enhances the efficiency of Anti-PD-1 immunotherapy in hepatocellular carcinoma
Junwei Kang
Zhiying Zheng
Xian Li
Tian Huang
Dawei Rong
Xinyang Liu
Miaomiao Qin
Yuliang Wang
Xiangyi Kong
Jinhua Song
Chengyu Lv
Xiongxiong Pan
Cancer Cell International, 22

← 1 2 3 4 5 →